New Blood Test Can Predict Heart Disease and Guide Prophylactic Treatment
AMPEL BioSolutions’ new CardioGENE blood test predicts heart disease by identifying genetic markers and inflammatory pathways.
Read MorePosted by Andy Lundin | Oct 18, 2024 | Cardiovascular, Molecular Diagnostics |
AMPEL BioSolutions’ new CardioGENE blood test predicts heart disease by identifying genetic markers and inflammatory pathways.
Read MorePosted by Andy Lundin | Oct 17, 2024 | Respiratory Disease |
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
Read MorePosted by Chris Wolski | Oct 10, 2024 | Sequencing Systems |
Reducing the incidence of healthcare-associated infections, and the antimicrobial resistance they can trigger, is critical for patient care.
Read MorePosted by Andy Lundin | Oct 8, 2024 | Leukemia, Sequencing Systems |
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read MorePosted by Andy Lundin | Oct 8, 2024 | Molecular Diagnostics |
Breakthrough Genomics is launching a new version of its fully-automated genome reader aimed at speeding up rare disease diagnosis.
Read More